Advertisement
Advertisement

ERAS

ERAS logo

Erasca Inc

2.52
USD
-0.115
-4.37%
Dec 18, 14:52 UTC -5
Open

Erasca Inc Profile

About

Erasca Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Erasca Inc. is based in SAN DIEGO.

Info & Links

CEO

Jonathan E. Lim

Headquarters

3115 MERRYFIELD ROW,SUITE 300
SAN DIEGO, CA 92121, UNITED STATES

Auditor

KPMG LLP

Share holders

55

Employees

126

Erasca Inc Statistics

Valuation Measures

Market Capitalization2

711.07M

Enterprise Value

642.18M

Enterprise Value/EBITDA(ttm)

-3.50

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.61

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-42.26%

Return on Invested Capital(ttm)

-42.46%

Return on Assets(ttm)

-34.97%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-183.26M

Net Income Available to Common(ttm)

-159.12M

Diluted EPS(ttm)

-0.83

Share Statistics

Beta (5Y Monthly)

1.20

52-Week Change

49.70%

S&P 500 52-Week Change

26.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

282.73M

Dividend Yield

0.00%

Float4

221.94M

% Held by Insiders

21.50%

% Held by Institutions

67.78%

Balance Sheet

Total Cash(mrq)

318.91M

Total Cash Per Share(mrq)

1.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.00%

Quick Ratio(mrq)

11.00%

Book Value Per Share(mrq)

2.97

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.30

Free Cash Flow(ytd)

-84.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement